Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,593,307
+$186,969 QoQ
Shares Held
1,327,757
-7.5% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.73865699823085.ToString("F0")%
Shared 0.ToString("F0")%
None 0.261343001769149.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. FATE ranks #235 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,593,307 | 1,327,757 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,406,338 | 1,435,040 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,872,871 | 1,486,407 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,813,076 | 2,511,676 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,942,588 | 2,458,974 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $4,086,083 | 2,476,414 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,881,910 | 2,823,403 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,703,256 | 2,348,554 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,769,973 | 2,012,258 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,210,312 | 590,993 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,048,266 | 494,466 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $5,163,804 | 1,084,833 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $7,573,366 | 1,328,661 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $8,173,262 | 810,036 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $23,345,101 | 1,041,727 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $26,878,122 | 1,084,670 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $8,780,513 | 226,477 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $23,823,574 | 407,171 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $33,838,605 | 570,923 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $51,504,831 | 593,442 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $67,571,237 | 819,542 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $70,508,394 | 775,414 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $52,319,410 | 1,308,967 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,792,054 | 1,043,196 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,534,656 | 744,469 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||